Frontier Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-42,660
| Closed | -$174K | – | 433 |
|
|
2018
Q1 | $174K | Sell |
42,660
-1,500
| -3% | -$6.12K | 0.02% | 366 |
|
|
2017
Q4 | $205K | Sell |
44,160
-13,500
| -23% | -$62.7K | 0.03% | 329 |
|
|
2017
Q3 | $409K | Sell |
57,660
-9,400
| -14% | -$66.7K | 0.06% | 258 |
|
|
2017
Q2 | $485K | Sell |
67,060
-4,050
| -6% | -$29.3K | 0.07% | 228 |
|
|
2017
Q1 | $438K | Sell |
71,110
-800
| -1% | -$4.93K | 0.07% | 243 |
|
|
2016
Q4 | $421K | Sell |
71,910
-4,600
| -6% | -$26.9K | 0.07% | 241 |
|
|
2016
Q3 | $406K | Sell |
76,510
-3,200
| -4% | -$17K | 0.06% | 234 |
|
|
2016
Q2 | $528K | Sell |
79,710
-1,700
| -2% | -$11.3K | 0.08% | 200 |
|
|
2016
Q1 | $380K | Sell |
81,410
-3,000
| -4% | -$14K | 0.03% | 228 |
|
|
2015
Q4 | $426K | Sell |
84,410
-13,000
| -13% | -$65.6K | 0.07% | 216 |
|
|
2015
Q3 | $343K | Buy |
97,410
+20,525
| +27% | +$72.3K | 0.05% | 237 |
|
|
2015
Q2 | $767K | Buy |
+76,885
| New | +$767K | 0.12% | 153 |
|